LGM Pharma invests $6 M in U.S. drug manufacturing capabilities for liquids, suspensions, semi-solids, and suppositories

URLhttps://www.news-medical.net/news/20250313/LGM-Pha
Sourcenews-medical.net
Date Published03/13/2025

Additional Reshoring Information:

Company/Division name LGM Pharma
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2025
Domestically, the work will be done:In-house
Capital investment ($):6
City reshored to:Rosenburg
State(s) reshored to:TX
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharmaceuticals
What non-domestic negative factors made offshoring less attractive?Supply chain interruption
Find Reshoring Articles